Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Odyssey Therapeutics Inc Share Price

ODTX

NAQ

$17.45

+$1.03

(6.27%)

Sector: Healthcare

Odyssey Therapeutics Inc Analyst Forecast

Overview Returns Financials Ratios News FAQs

Odyssey Therapeutics Inc Share Price Chart

Odyssey Therapeutics Inc Key Stock Metrics

Market Cap

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$738.81M

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

Volume

This is the total number of shares traded during the most recent trading day.

426.89K

Avg Volume

This is the average number of shares traded during the most recent 30 days.

Dividend Yield

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

52-week Range

This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$15.41 L

$20.3 H

$17.45

About Odyssey Therapeutics Inc, Common Stock

Odyssey Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It is developing medicines that are designed to precisely target disease pathology with an initial emphasis on the innate immune system. Its advanced programs include OD-001, an oral small-molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, and OD-002, an oral small-molecule inhibitor of solute carrier family 15 member 4, or SLC15A4. These programs have the potential to yield treatments for inflammatory and autoimmune diseases. In addition to its advanced programs, it has a portfolio of preclinical programs that include a regulatory T cell, or Treg, -specific tumor necrosis factor receptor 2, or TNFR2, agonist, a bispecific antagonist of thymic stromal lymphopoietin, or TSLP, and interleukin-33, or IL-33, and an interleukin-1 receptor-associated kinase 4, or IRAK4, scaffolding inhibitor. It also has an interferon regulatory factor 5, or IRF5, inhibitor in preclinical development. more

Sector: Healthcare

Odyssey Therapeutics Inc Stock Returns

Data is not properly formatted.

Time Frame	ODTX		S&P500
1-Week Return	-3.06%%	%	2.71%%

Odyssey Therapeutics Inc Financials

	Dec '22	Dec '23	Dec '24	Dec '25
Total Revenue	-	1.04M	4.47M	2.98M	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":23.19,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":66.55,"profit":true}]
Cost of Revenue	-	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Gross Profit	-	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Gross Margin	-	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]

Operating Expenses	122.78M	134.48M	139.69M	164.13M	[{"date":"2022-12-31","value":74.8,"profit":true},{"date":"2023-12-31","value":81.93,"profit":true},{"date":"2024-12-31","value":85.11,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Operating Income	(122.78M)	(133.44M)	(135.22M)	(161.16M)	[{"date":"2022-12-31","value":-12277600000,"profit":false},{"date":"2023-12-31","value":-13343900000,"profit":false},{"date":"2024-12-31","value":-13522300000,"profit":false},{"date":"2025-12-31","value":-16115600000,"profit":false}]
Total Non-Operating Income/Expense	(1.54M)	7.95M	6.37M	11.58M	[{"date":"2022-12-31","value":-13.31,"profit":false},{"date":"2023-12-31","value":68.62,"profit":true},{"date":"2024-12-31","value":55.01,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Pre-Tax Income	(124.32M)	(125.49M)	(128.85M)	(149.57M)	[{"date":"2022-12-31","value":-12431800000,"profit":false},{"date":"2023-12-31","value":-12549100000,"profit":false},{"date":"2024-12-31","value":-12885200000,"profit":false},{"date":"2025-12-31","value":-14957400000,"profit":false}]
Income Taxes	-	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Income After Taxes	-	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]

Income From Continuous Operations	(124.67M)	(125.94M)	(129.32M)	(148.65M)	[{"date":"2022-12-31","value":-12466500000,"profit":false},{"date":"2023-12-31","value":-12593800000,"profit":false},{"date":"2024-12-31","value":-12932100000,"profit":false},{"date":"2025-12-31","value":-14864700000,"profit":false}]
Income From Discontinued Operations	-	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Net Income	(124.67M)	(125.94M)	(129.32M)	(148.65M)	[{"date":"2022-12-31","value":-12466500000,"profit":false},{"date":"2023-12-31","value":-12593800000,"profit":false},{"date":"2024-12-31","value":-12932100000,"profit":false},{"date":"2025-12-31","value":-14864700000,"profit":false}]

EPS (Diluted)	-	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]

	Dec '22	Dec '23	Dec '24	Dec '25
Total Revenue	-	-	331.24%	(33.45%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":-10.1,"profit":false}]
Cost of Revenue	-	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Gross Profit	-	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Gross Margin	-	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]

Operating Expenses	-	9.53%	3.88%	17.49%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":54.48,"profit":true},{"date":"2024-12-31","value":22.19,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Operating Income	-	8.68%	1.34%	19.18%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":45.29,"profit":true},{"date":"2024-12-31","value":6.97,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense	-	(615.43%)	(19.84%)	81.79%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-752.43,"profit":false},{"date":"2024-12-31","value":-24.26,"profit":false},{"date":"2025-12-31","value":100,"profit":true}]
Pre-Tax Income	-	0.94%	2.68%	16.08%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":5.87,"profit":true},{"date":"2024-12-31","value":16.65,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Income Taxes	-	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Income After Taxes	-	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]

Income From Continuous Operations	-	1.02%	2.69%	14.94%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":6.83,"profit":true},{"date":"2024-12-31","value":17.98,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Income From Discontinued Operations	-	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Net Income	-	1.02%	2.69%	14.94%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":6.83,"profit":true},{"date":"2024-12-31","value":17.98,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]

EPS (Diluted)	-	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]

	Dec '24
Total Revenue	1.75M	[{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue	-	[{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit	-	[{"date":"2024-12-31","value":"-","profit":true}]
Gross Margin	-	[{"date":"2024-12-31","value":"-","profit":true}]

Operating Expenses	38.88M	[{"date":"2024-12-31","value":100,"profit":true}]
Operating Income	(37.12M)	[{"date":"2024-12-31","value":-3712100000,"profit":false}]
Total Non-Operating Income/Expense	1.24M	[{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income	(35.88M)	[{"date":"2024-12-31","value":-3588500000,"profit":false}]
Income Taxes	-	[{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes	-	[{"date":"2024-12-31","value":"-","profit":true}]

Income From Continuous Operations	(35.93M)	[{"date":"2024-12-31","value":-3593200000,"profit":false}]
Income From Discontinued Operations	-	[{"date":"2024-12-31","value":"-","profit":true}]
Net Income	(35.93M)	[{"date":"2024-12-31","value":-3593200000,"profit":false}]

EPS (Diluted)	-	[{"date":"2024-12-31","value":"-","profit":true}]

	Dec '24
Total Revenue	-	[{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue	-	[{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit	-	[{"date":"2024-12-31","value":"-","profit":true}]
Gross Margin	-	[{"date":"2024-12-31","value":"-","profit":true}]

Operating Expenses	-	[{"date":"2024-12-31","value":"-","profit":true}]
Operating Income	-	[{"date":"2024-12-31","value":"-","profit":true}]
Total Non-Operating Income/Expense	-	[{"date":"2024-12-31","value":"-","profit":true}]
Pre-Tax Income	-	[{"date":"2024-12-31","value":"-","profit":true}]
Income Taxes	-	[{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes	-	[{"date":"2024-12-31","value":"-","profit":true}]

Income From Continuous Operations	-	[{"date":"2024-12-31","value":"-","profit":true}]
Income From Discontinued Operations	-	[{"date":"2024-12-31","value":"-","profit":true}]
Net Income	-	[{"date":"2024-12-31","value":"-","profit":true}]

EPS (Diluted)	-	[{"date":"2024-12-31","value":"-","profit":true}]

	Dec '22	Dec '23	Dec '24	Dec '25
Total Assets
Current Assets	248.71M	192.54M	135.51M	190.66M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":77.41,"profit":true},{"date":"2024-12-31","value":54.48,"profit":true},{"date":"2025-12-31","value":76.66,"profit":true}]
Non-current Assets	68.44M	93.98M	61.92M	79.13M	[{"date":"2022-12-31","value":72.82,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":65.89,"profit":true},{"date":"2025-12-31","value":84.2,"profit":true}]
Total Assets	317.15M	286.52M	197.44M	269.79M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":90.34,"profit":true},{"date":"2024-12-31","value":62.25,"profit":true},{"date":"2025-12-31","value":85.07,"profit":true}]

Total Liabilities
Current Liabilities	22.80M	22.09M	28.41M	26.48M	[{"date":"2022-12-31","value":80.23,"profit":true},{"date":"2023-12-31","value":77.73,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":93.17,"profit":true}]
Non-current Liabilities	438.97M	527.14M	551.55M	731.59M	[{"date":"2022-12-31","value":60,"profit":true},{"date":"2023-12-31","value":72.05,"profit":true},{"date":"2024-12-31","value":75.39,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Total Liabilities	461.77M	549.23M	579.96M	758.07M	[{"date":"2022-12-31","value":60.91,"profit":true},{"date":"2023-12-31","value":72.45,"profit":true},{"date":"2024-12-31","value":76.51,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Retained Earnings	(158.17M)	(289.09M)	(419.49M)	(568.14M)	[{"date":"2022-12-31","value":-15817100000,"profit":false},{"date":"2023-12-31","value":-28909100000,"profit":false},{"date":"2024-12-31","value":-41949200000,"profit":false},{"date":"2025-12-31","value":-56813900000,"profit":false}]
Other Stockholders' Equity	-	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Total Shareholders' equity	(144.62M)	(262.71M)	(382.53M)	(488.28M)	[{"date":"2022-12-31","value":-14462000000,"profit":false},{"date":"2023-12-31","value":-26270800000,"profit":false},{"date":"2024-12-31","value":-38252700000,"profit":false},{"date":"2025-12-31","value":-48827800000,"profit":false}]

Total Liabilities & Shareholders Equity	317.15M	286.52M	197.44M	269.79M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":90.34,"profit":true},{"date":"2024-12-31","value":62.25,"profit":true},{"date":"2025-12-31","value":85.07,"profit":true}]

	Dec '22	Dec '23	Dec '24	Dec '25
Total Assets
Current Assets	-	(22.59%)	(29.62%)	40.70%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-55.5,"profit":false},{"date":"2024-12-31","value":-72.78,"profit":false},{"date":"2025-12-31","value":100,"profit":true}]
Non-current Assets	-	37.33%	(34.11%)	27.79%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-91.38,"profit":false},{"date":"2025-12-31","value":74.44,"profit":true}]
Total Assets	-	(9.66%)	(31.09%)	36.65%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-26.35,"profit":false},{"date":"2024-12-31","value":-84.84,"profit":false},{"date":"2025-12-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	-	(3.11%)	28.65%	(6.83%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-10.87,"profit":false},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":-23.83,"profit":false}]
Non-current Liabilities	-	20.09%	4.63%	32.64%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":61.53,"profit":true},{"date":"2024-12-31","value":14.18,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Total Liabilities	-	18.94%	5.60%	30.71%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":61.67,"profit":true},{"date":"2024-12-31","value":18.22,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Retained Earnings	-	82.77%	45.11%	35.44%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":54.5,"profit":true},{"date":"2025-12-31","value":42.81,"profit":true}]
Other Stockholders' Equity	-	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Total Shareholders' equity	-	81.65%	45.61%	27.65%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":55.86,"profit":true},{"date":"2025-12-31","value":33.86,"profit":true}]

Total Liabilities & Shareholders Equity	-	(9.66%)	(31.09%)	36.65%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-26.35,"profit":false},{"date":"2024-12-31","value":-84.84,"profit":false},{"date":"2025-12-31","value":100,"profit":true}]

	Sep '24	Dec '24
Total Assets
Current Assets	159.83M	135.51M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":84.78,"profit":true}]
Non-current Assets	61.70M	61.92M	[{"date":"2024-09-30","value":99.64,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Assets	221.53M	197.44M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":89.12,"profit":true}]

Total Liabilities
Current Liabilities	25.11M	28.41M	[{"date":"2024-09-30","value":88.35,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Non-current Liabilities	545.70M	551.55M	[{"date":"2024-09-30","value":98.94,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Liabilities	570.80M	579.96M	[{"date":"2024-09-30","value":98.42,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Retained Earnings	(382.66M)	(419.49M)	[{"date":"2024-09-30","value":-38265600000,"profit":false},{"date":"2024-12-31","value":-41949200000,"profit":false}]
Other Stockholders' Equity	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Total Shareholders' equity	(349.27M)	(382.53M)	[{"date":"2024-09-30","value":-34926600000,"profit":false},{"date":"2024-12-31","value":-38252700000,"profit":false}]

Total Liabilities & Shareholders Equity	221.53M	197.44M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":89.12,"profit":true}]

	Sep '24	Dec '24
Total Assets
Current Assets	-	(15.22%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false}]
Non-current Assets	-	0.36%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Assets	-	(10.88%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false}]

Total Liabilities
Current Liabilities	-	13.18%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Non-current Liabilities	-	1.07%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Liabilities	-	1.60%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Retained Earnings	-	9.63%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Other Stockholders' Equity	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Total Shareholders' equity	-	9.52%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	-	(10.88%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false}]

	Dec '22	Dec '23	Dec '24	Dec '25
Operating Activities
Net Operating Cash Flow	(99.84M)	(112.73M)	(117.47M)	(129.47M)	[{"date":"2022-12-31","value":-9984200000,"profit":false},{"date":"2023-12-31","value":-11272800000,"profit":false},{"date":"2024-12-31","value":-11747100000,"profit":false},{"date":"2025-12-31","value":-12946800000,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	182.72M	92.08M	26.98M	215.65M	[{"date":"2022-12-31","value":84.73,"profit":true},{"date":"2023-12-31","value":42.7,"profit":true},{"date":"2024-12-31","value":12.51,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]

Net Change in Cash	69.83M	(185.67M)	6.34M	(17.45M)	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-265.9,"profit":false},{"date":"2024-12-31","value":9.08,"profit":true},{"date":"2025-12-31","value":-24.99,"profit":false}]

Free Cash Flow
Free Cash Flow	(112.87M)	(117.78M)	(118.23M)	(130.70M)	[{"date":"2022-12-31","value":-11286900000,"profit":false},{"date":"2023-12-31","value":-11778400000,"profit":false},{"date":"2024-12-31","value":-11823500000,"profit":false},{"date":"2025-12-31","value":-13070000000,"profit":false}]

	Dec '22	Dec '23	Dec '24	Dec '25
Operating Activities
Net Operating Cash Flow	-	12.91%	4.21%	10.21%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":32.6,"profit":true},{"date":"2025-12-31","value":79.13,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	(49.61%)	(70.70%)	699.31%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-7.09,"profit":false},{"date":"2024-12-31","value":-10.11,"profit":false},{"date":"2025-12-31","value":100,"profit":true}]

Net Change in Cash	-	(365.90%)	(103.42%)	(375.13%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-12-31","value":null,"profit":false}]

Free Cash Flow
Free Cash Flow	-	4.35%	0.38%	10.54%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":41.3,"profit":true},{"date":"2024-12-31","value":3.63,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]

	Dec '24
Operating Activities
Net Operating Cash Flow	(34.29M)	[{"date":"2024-12-31","value":-3428800000,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	[{"date":"2024-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	6.82M	[{"date":"2024-12-31","value":100,"profit":true}]

Net Change in Cash	19.70M	[{"date":"2024-12-31","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	(34.55M)	[{"date":"2024-12-31","value":-3455300000,"profit":false}]

	Dec '24
Operating Activities
Net Operating Cash Flow	-	[{"date":"2024-12-31","value":"-","profit":true}]

Investing Activities
Net Investing Cash Flow	-	[{"date":"2024-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	[{"date":"2024-12-31","value":"-","profit":true}]

Net Change in Cash	-	[{"date":"2024-12-31","value":"-","profit":true}]

Free Cash Flow
Free Cash Flow	-	[{"date":"2024-12-31","value":"-","profit":true}]

Odyssey Therapeutics Inc Ratios

Odyssey Therapeutics Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	ODTX
ROA (LTM)	0.00%
ROE (LTM)	0.00%

Odyssey Therapeutics Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	ODTX
Trailing PE	NM
Forward PE	NM
P/S (TTM)	0.00
P/B	0.00
EV/R	0.00
EV/Ebitda	NM

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Odyssey Therapeutics Inc share price today?

Odyssey Therapeutics Inc (ODTX) share price today is $17.45

Can Indians buy Odyssey Therapeutics Inc shares?

Yes, Indians can buy shares of Odyssey Therapeutics Inc (ODTX) on Vested. To buy from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ODTX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Odyssey Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of Odyssey Therapeutics Inc (ODTX) via the Vested app. You can start investing in Odyssey Therapeutics Inc (ODTX) with a minimum investment of $1.

How to invest in Odyssey Therapeutics Inc shares from India?

You can invest in shares of Odyssey Therapeutics Inc (ODTX) via Vested in three simple steps:

Click on Sign Up or Invest in ODTX stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Odyssey Therapeutics Inc shares

What is Odyssey Therapeutics Inc 52-week high and low stock price?

The 52-week high price of Odyssey Therapeutics Inc (ODTX) is $20.3. The 52-week low price of Odyssey Therapeutics Inc (ODTX) is $15.41.

What is Odyssey Therapeutics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Odyssey Therapeutics Inc (ODTX) is

What is Odyssey Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Odyssey Therapeutics Inc (ODTX) is 0.00

What is Odyssey Therapeutics Inc dividend yield?

The dividend yield of Odyssey Therapeutics Inc (ODTX) is 0.00%

What is the Market Cap of Odyssey Therapeutics Inc?

The market capitalization of Odyssey Therapeutics Inc (ODTX) is $738.81M

What is Odyssey Therapeutics Inc's stock symbol?

The stock symbol (or ticker) of Odyssey Therapeutics Inc is ODTX

How Can Investors Use Odyssey Therapeutics Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Odyssey Therapeutics Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Odyssey Therapeutics Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Odyssey Therapeutics Inc shares for Indian investors?

When investing in Odyssey Therapeutics Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Odyssey Therapeutics Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Odyssey Therapeutics Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Odyssey Therapeutics Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Odyssey Therapeutics Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.